Ocugen Inc (OCGN)

NASDAQ HEALTHCARE
$1.68 +1.20% RSI 42 Neutral Add Alert

Moving Averages

SMA 200
$1.42
Price above

Company Profile

Ocugen, Inc., a clinical-stage biopharmaceutical company, focuses on the development of gene therapies to cure diseases of blindness. The company is headquartered in Malvern, Pennsylvania.

Sector
HEALTHCARE
Industry
BIOTECHNOLOGY
Market Cap
$577.10M
P/E Ratio
None
EPS
$-0.23
Beta
2.813
Dividend Yield
0.00%
52-Week High
$2.725
52-Week Low
$0.64

Similar stocks in BIOTECHNOLOGY

BNTX
BioNTech SE
RSI 57.0
VRTX
Vertex Pharmaceuticals Inc
RSI 41.0
CRSP
CRISPR Therapeutics AG
RSI 50.0
RXRX
Recursion Pharmaceuticals Inc - Class A
RSI 50.0
MRNA
Moderna Inc
RSI 36.0
VKTX
Viking Therapeutics Inc
RSI 38.0

Data last updated: April 11, 2026 at 10:57 AM EDT

Track OCGN for free

Get e-mail RSI alerts when Ocugen Inc enters oversold or overbought territory. Free forever.

Add Alert